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ABSTRACT 
Obstructive sleep apnoea (OSA) is a common disease that leads to daytime sleepiness and 
cognitive impairment. Attempts to investigate changes in brain morphology that may underlie these 
impairments have led to conflicting conclusions. We aimed to resolve this confusion and determine 
whether OSA is associated with changes in brain morphology, by studying a large group of OSA 
patients, using improved voxel based morphometry (VBM) analysis; an automated, unbiased 
method of detecting local changes in brain structure. 
Methods: 60 OSA patients (Mean, confidence intervals) apnoea hypopnoea index [AHI] 55(48-
62)events/hr, 3 female) and 60 non-apnoeic controls (AHI 4(3-5)events/hr, 5 female), were studied. 
Subjects were imaged using T1-weighted 3D structural MRI (69 subjects at 1.5T, 51 subjects at 
3T). OSA grey matter differences were investigated, controlling for age, sex, site and intracranial 
volume. Dedicated cerebellar analysis was performed on a subset of 108 scans using a Spatially 
Unbiased Infra-Tentorial Template. 
Results: OSA patients had a reduction in grey matter volume in the right middle temporal gyrus, 
compared to non-apnoeic controls (p<0.05, corrected for topological false discovery rate across 
the entire brain). A reduction in grey matter was also seen within the cerebellum, maximal in the 
left lobe VIIIb close to XI, extending across the midline into the right lobe. 
Conclusion: These data show that OSA is associated with focal loss of grey matter that could 
contribute to cognitive decline. Specifically, lesions in the cerebellum may result in both motor 
dysfunction and working memory deficits, with downstream negative consequences on tasks such 
as driving. 




Obstructive sleep apnoea (OSA) is a common disorder that causes intermittent hypoxia and 
frequent arousals from sleep, leading to extreme daytime sleepiness and increased cardiovascular 
risk (1, 2). There is also a well recognised link between OSA and cognitive impairment (3-5), with 
OSA patients being more 2-4 times more likely to have a road traffic accident (6). Specific 
impairments include reductions in working memory, phonological fluency, cognitive flexibility and 
planning; these can reduce efficiency at work, the ability to learn new tasks, and remember 
instructions (7). Despite this link between OSA and cognitive impairment, little is known about 
neural deficits that may underlie these sequelæ. Changes in neural activation associated with 
cognitive impairment (8-13) and autonomic dysfunction (14) have been recorded using functional 
magnetic resonance imaging (fMRI) in OSA patients; it is possible these functional changes are 
due to structural deficits. 
Severe hypoxia and anoxia results in diffuse neurodegeneration (15), whereas exposure to 
intermittent hypoxia has been shown to produce cellular damage within the CA1 region of the 
hippocampus and adjacent cortex in rats (16). In OSA patients, several studies have employed 
voxel based morphometry (VBM) techniques to analyse structural magnetic resonance (MR) brain 
scans for changes in brain morphology (17-20). VBM enables voxel-wise comparisons of grey 
matter volume between two groups across the whole brain (21). Detection of a reduction in grey 
matter reflects neural damage or hypotrophy and is observed in a number of brain diseases, as 
well as normal aging towards the latter part of life (22). 
Diffuse changes in grey matter concentration across the entire brain have been found in 
OSA patients using VBM techniques; including the frontal, parietal and temporal cortices, anterior 
cingulate, hippocampus and cerebellum (17) and bilateral prefrontal cortex, inferior parietal gyrus, 
right temporal and occipital cortices, right thalamus, some of the basal ganglia, right hippocampus 
and parahippocampal gyrus and cerebellum (right cerebellar hemisphere and vermis) (20). 
However, these studies used a relatively low threshold for statistical significance (p<0.001) 
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uncorrected for multiple comparisons (17), or contained relatively few patients (n=16; 20). A 
smaller focal loss of grey matter within the left hippocampus was found in a very small group (n=7) 
of OSA patients, using a level of significance selected on the basis of an a priori hypothesis (18). In 
contrast, a more stringent analysis (p<0.05, corrected for multiple comparisons using false 
discovery rate [FDR]) showed no significant reductions in grey matter (19). All these studies had 
relatively small sample sizes (between 7 and 27 patients), they utilised different statistical 
thresholds and covariants, and some included patients with known co-morbidities, which might 
affect brain structure. This has resulted in confusion within the field. The present study aimed to 
determine whether OSA is associated with a focal loss of grey matter by studying a relatively large 
group of OSA patients (n=60) compared to a group of controls (n=60) of similar age and gender, 
using standardised improved methods of VBM analysis. Analyses of 60 of the 120 scans presented 





Patients were recruited from sleep clinics in Melbourne, Australia (Department of 
Respiratory and Sleep Medicine, Austin Health) and London, UK (The Royal Brompton, and 
Charing Cross Hospitals). Patients with an apnoea/hypoponea index (AHI) > 30 events/hour were 
invited to participate in the study. The Melbourne patients also had to have at least 15% of total 
sleep time spent at SaO2 less than 90%. Exclusion criteria were a clinical diagnosis or history of 
respiratory disease, cerebrovascular or ischemic heart disease, diabetes mellitus, central nervous 
system disorders (neurodegenerative diseases, epilepsy, head injury, psychosis, hypothyroidism, 
current depression), alcohol or illicit drug abuse, or current intake of psychoactive medications. 
Healthy controls were recruited by newspaper advertisement, and through our data base of healthy 
volunteers. In addition to the exclusion criteria above, the controls were also excluded from 
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participation if they had a history of habitual snoring or any other sleep complaint. All control 
subjects were screened with polysomnography and questionnaire to exclude OSA. 
Apnoeas were defined as >80% drop in airflow for ≥ 10s in the London data set, and a 
complete cessation of airflow for ≥ 10 s in the Melbourne data set. Hypopnoeas were defined as > 
50% reduction in airflow from baseline with a > 4% dip in saturation, or an arousal from sleep in the 
London data set, and >50% decrease in airflow without a requirement for associated oxygen 
desaturation or arousal, plus those with a lesser airflow reduction in association with oxygen 
desaturation of > 3% or an arousal in the Melbourne data set. Control subjects had an AHI < 5 
events/hour when airflow was measured by thermistor, or < 15 events/hour when airflow was 
measured by nasal cannula (23,24). The study was approved by Research and Ethics Committees 
in both institutions and all subjects gave informed written consent. 
MRI Protocol 
Twenty six OSA patients and 25 healthy controls were studied in Melbourne, Australia. T1-
weighted MR images were acquired using a 3.0 tesla scanner (General Electrics Horizon LX). A 
fast spoiled, gradient-recalled echo at steady state sequence (time to repeat (TR) of 13.8 ms, time 
to echo (TE) of 2.7 ms, time to inversion (TI) of 500 ms in-plane resolution 0.49 x 0.49 mm) with 
contiguous coronal slices of 2 mm thickness was used. Thirty four OSA patients and 35 healthy 
controls were studied in London, UK. T1-weighted MR images were acquired using a 1.5 tesla 
scanner (Siemens, Vision), and a 3D MP-RAGE sequence (Time to inversion 300 ms, TE 4 ms, in-
plane resolution 1.0 x 1.0 mm), with contiguous 2 mm coronal slices. 
Voxel Based Morphometry  
VBM is an objective, whole-brain approach that enables comparisons of regional volumetric 
differences between groups (21). Briefly, VBM involves the segmentation of anatomical T1 
weighted MR scans into grey matter, white matter and cerebrospinal fluid. The grey matter 
segments are then spatially normalised into standard stereotactic space using non-linear 
regression to align homologous regions across subjects. The resulting grey matter images are 
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spatially smoothed to account for any remaining variation in gyral anatomy between individuals, 
and to reduce spatial noise. Statistical analysis using the general linear model is performed to 
localize group differences using dedicated brain image analysis software (SPM; 
www.fil.ion.ucl.ac.uk/spm). The “optimised VBM” process utilised by previous publications in this 
field (17-19) has now been improved by procedures within the current SPM software (SPM8) which 
provides higher quality spatial normalisation and segmentation; indeed these steps are now 
combined (see below). In addition, SPM8 allows control of the false discovery rate (FDR; a method 
used for controlling the false-positive rate when performing multiple tests) of topological features 
(i.e. clusters of voxels) which is more appropriate than controlling the FDR of individual voxels (25) 
as used in previous studies (19). The analysis output is produced in the form of a statistical 
parametric map (SPM) displaying voxels in which grey matter volume is significantly different to 
that which occurs in a control group. 
In the present study, the segmentation and normalisation steps were combined within a 
unified probabilistic framework provided in SPM8 (26). In separate analyses the modulated grey 
matter segments were smoothed using either 8 or 12 mm Gaussian full-width-half-maximum 
smoothing kernels, and saved at a voxel size of 2 x 2 x 2 mm. The total intracranial volume was 
then calculated as the sum of the grey matter, white matter and cerebrospinal fluid segments over 
the whole brain. 
Spatially Unbiased Infra-tentorial Template (SUIT) analysis 
There are intrinsic difficulties in the analysis of MR images of the cerebellum (27). In 
particular for VBM, standard spatial normalisation templates are optimised for the cortex and not 
for the cerebellum. These shortcomings in the standard template result in sub-optimal grey matter 
segmentation of cerebellar tissues, and potential inclusion of non cerebellar tissue within the region 
of interest (27); factors that reduce accuracy and sensitivity. Furthermore, signal drop out can be 
relatively high in the cerebellum due to local field inhomogeneities. To address these issues, we 
performed an additional analysis of the cerebellum using spatial segmentation and normalisation 
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with a dedicated cerebellar template (spatially unbiased infra-tentorial template: SUIT 2.2) (27). 
This template, based on the average anatomy of 20 healthy individuals, better preserves the 
anatomical detail of the cerebellum compared to the Montreal Neurological Institute whole-brain 
template. The SUIT approach has been shown to increase the sensitivity of functional imaging 
studies which require accurate cerebellar normalisation, by about 15% (27). 
In brief, the MR image was masked using the cerebellum template before normalisation, 
such that no supra-tentorial grey matter can bias the results. The subsequent normalisation and 
segmentation process used this cropped image and a classification map to create a nonlinear 
deformation map matched to the SUIT template, using the cosine-basis function approach (28). 
Finally, the images were resliced into the new atlas space and smoothed with 8 mm and 12 mm 
kernels. 
Statistical Analysis 
Subject characteristics, including age, body mass index (BMI), and sleep disordered 
breathing parameters were tested using independent samples t-tests, to compare the OSA patients 
and healthy controls. 
Normalised (non-linearly registered) GM images were compared using a factorial design 
with site (London and Melbourne) and diagnosis (OSA patients and healthy controls) as factors. 
Age, sex, and intracranial volume were included as covariates. By modelling the data in this way, 
we were able to investigate the differences in grey matter volume between OSA patients and 
healthy controls, after adjusting for inter-site differences in the imaging equipment and acquisition 
parameters. 
Statistical parametric maps were first thresholded at P<0.001 uncorrected for multiple 
comparisons, and then inferences about regionally specific grey matter volume differences were 
made using a significance threshold level of P<0.05, corrected for topological FDR across the 
whole brain (25). For the cerebellar analysis, conducted as a post-hoc comparison, the statistical 
threshold was set using a more stringent correction for multiple comparisons (p < 0.05 family wise 
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error (FWE)) across the cerebellum. These thresholds were chosen as the standard minimal 
acceptable to exclude excessive false positives (29). To assess the spatial homogeneity of the 
sensitivity to detect an effect, a sensitivity map was constructed that indicated the minimum change 
in grey matter volume required for each voxel to reach significance at P<0.001 uncorrected, 
following a variation of the method described in the appendix of Abbott et al., 2009 (30). 
Specifically, rather than expressing sensitivity of each voxel as a percentage change in volume, we 
expressed sensitivity as absolute change in volume in the same units as the contrast images i.e. 
we did not multiply by 100/local mean of the voxel.  
The cerebellar SUIT analysis was conducted using a similar statistical model to that for the 
whole brain. Differences in overall cerebellar/brainstem volume were accounted for by including 
the combined grey and white matter volume of the segmented region as a covariate. One hundred 
and eight MR brain scans (52 OSA patients, and 56 healthy controls) were included in the SUIT 
analysis. Twelve scans (8 OSA patients, and 4 healthy controls) were excluded due to poor 
cerebellar image quality, or problems with segmentation in the cerebellum. 
 
RESULTS 
One hundred and twenty MR brain scans were analysed. Subject characteristics are given 
in Table 1. Sixty patients with severe OSA were studied; 26 were recruited in Melbourne and 34 in 
London. Sixty healthy controls were also studied; 25 in Melbourne and 35 in London. Overall, OSA 
patients had a higher AHI, oxygen desaturation index, BMI and subjective sleepiness score 
(Epworth Sleepiness Scale; ESS) when compared to healthy controls (all p<0.001). There was no 
significant difference in the age between the two groups (p=0.68). 
OSA patients had a significant reduction in grey matter volume in the right middle temporal 
gyrus, extending along the occipito-temporal sulcus inferiorly (p<0.05 corrected for topological FDR 
across the entire brain) compared to healthy controls (Fig 1A). The outcome of the statistical 
analysis was similar for both the 8 mm and 12 mm smoothing kernels applied in pre-processing. 
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The whole brain analysis also showed a significant reduction in cerebellar grey matter volume in a 
single bilateral region, with greatest extent and the voxel-wise statistical maximum within the left 
lobe (Fig 1B). This finding was confirmed using the SUIT analysis, the location of the grey matter 
loss being within the left cerebellum lobe VIIIb but close to IX (p<0.05 corrected for FWE across 
the cerebellum; Fig 2). 
The sensitivity analysis showed homogeneity in the ability to detect change throughout the 
brain, except for the brainstem and adjacent to the interhemispheric fissure (Fig 3). The mean 
sensitivity within the regions of significant volume loss was 0.054 (SD 0.007). To assess where in 
the brain sensitivity was approximately as good, or better than the regions in which there was a 
significant finding, we displayed the sensitivity map in pseudo-colour such that cool colours (blue 
and green) indicate sensitivity as good, or better than two standard deviations above the mean 
sensitivity of the regions of significant volume loss (i.e. 0.067). Warm colours in the figure indicate 
areas where a larger volume change would be required before we could detect it in our study. This 
is about twice the sensitivity of our previous study (19). Maps showing the effect size associated 
with the change in grey matter are shown in Fig 4. They indicate larger changes in the right 
temporal cortex and in the left cerebellum; changes that are consistent with the patterns of 
statistical significance.  
 
DISCUSSION  
Our study demonstrates that regional grey matter loss does occur in patients with OSA. 
Using improved VBM analysis techniques, in a relatively large data set we found a reduction in 
grey matter volume in the right temporal lobe and left cerebellum of patients with severe OSA. The 
functional consequences of these structural deficits remain to be determined. 
The impact of different VBM analysis techniques on grey matter loss 
Our findings are consistent with previous studies (17,20) which reported grey matter loss in 
the temporal lobe and cerebellum of OSA patients. However, our data do not confirm previous 
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reports of grey matter changes in the frontal and parietal cortices, anterior cingulate or the 
hippocampus (17,18,20); areas important in autonomic regulation as well as cognitive function. 
The differences between the findings of the present study, compared to previous studies cannot be 
explained by heterogeneity in sensitivity to detect reductions in grey matter volume in these 
regions. Our sensitivity map revealed relativity homogeneous sensitivity throughout most of the 
brain. Therefore, the contradiction between the areas of grey matter volume reduction in our study 
verses previous studies may be explained by our use of improved image analysis techniques and 
appropriate statistical thresholds. It has been argued that the use of analysis thresholds that are 
too stringent will mask small differences in grey matter concentration between OSA patients and 
controls (31). Nevertheless, some form of correction for multiple comparisons is required when 
using VBM techniques for whole brain comparisons, to account for the very large number of voxels 
that make up the brain volume (19, 29). Our level of inference differs from previous studies (18,19) 
in that we control for topological FDR across the entire brain. We chose this statistical threshold 
because lenient uncorrected thresholds are usually considered appropriate only for exploratory 
analyses, voxel-level FDR suffers from ambiguity in interpretation, and voxel-level FWE can be too 
stringent if correcting across all brain voxels. Topological FDR provides a more appropriate level of 
control for Type I and II errors when investigating where regions of grey matter loss occur across 
the brain (25).  
It has also been suggested that the magnitude of the changes in grey matter volume that 
occur in patients with OSA are similar to those seen with aging, and that apnoea-related changes 
may be missed if age is not included in an analysis of covariance model (31). In both the present 
study, and the previous study of O’Donoghue et al. (19) age was included in the analysis of 
covariance, replicating this aspect of the analysis model of Macey et al. (17). The use of the 12 mm 




Grey matter loss in the temporal lobe 
The decreased grey matter volume observed in the right middle temporal gyrus in OSA 
patients is consistent with previous reports (17,20). These studies also found reductions in grey 
matter in the inferior temporal gyrus, including the parahippocampal gyrus, and extending towards 
the anterior temporal pole (17,20). The precise function of the middle temporal gyrus is unclear. 
However, it is noteworthy that this area is susceptible to hypoxic damage in an animal model of 
OSA (16). 
Recent attempts to link the structural deficits in OSA patients with functional consequences, 
have concluded that structural deficits are associated with only minor memory and motor 
impairments (20). Therefore, it would appear that the structural deficits precede the functional 
consequences. Alternatively, only minor functional consequences may have been found if OSA 
patients are able to compensate for structural deficits by increasing neuronal activation. Support  
for this suggestion is that brain activation is greater during verbal learning tasks performed by 
healthy people in a sleep-deprived state compared to a non-sleep deprived state (32) and in OSA 
patients compared to controls (9). 
Grey matter loss in the cerebellum 
The whole brain analysis, controlling for topological FDR, suggested grey matter loss in a 
single large region of the cerebellum extending bilaterally, but appearing to be more dominant on 
the left. As this was only a single region, identified whilst controlling for topological FDR, it is 
difficult to be specific about the localisation of grey matter loss within the region. When thresholded 
at P<0.05 corrected for FWE across the whole brain, the only portion of the region that survived 
was on the left. The issues associated with analysis of MR images of the cerebellum have been 
previously noted (27). Accordingly we carried out our additional analysis using the SUIT technique 
to confirm the region of change. The SUIT analysis showed that the dominant region of grey matter 
loss was indeed lateralised to a limited area in the left cerebellum (Fig 2). 
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The notion that OSA leads to cerebellar damage is intriguing. The cerebellum has a broad 
range of functions. Patients with right focal lesions often show verbal deficits, whereas those with 
lesions on the left appear to suffer from more spatial deficits (33). In particular the left VIIIB location 
has been highlighted as being involved in motor processing (34). Moreover, the links between the 
cerebellum and prefrontal activation suggest that working memory tasks which require a quick shift 
of attention may be impaired (35). Finally, cerebellum activation is increased during simulated 
driving (36). We speculate impairments in attention and working memory, in association with 
excessive daytime sleepiness, could have negative consequences for daily tasks carried out by 
OSA patients, and may in part explain the OSA-related increased risk of road traffic accidents (6). 
An alternative view is that neural deficits in cerebellum may actually exacerbate, or even cause 
sleep apnoea (37). Recent data, which shows a reduction in grey matter volume in the cerebellum 
of older people with previously undiagnosed sleep disordered breathing, could support this idea 
(38); whether such lesions preceed the development of sleep apnoea is unknown. 
Other Imaging modalities 
Other methods of MR analysis, such as diffusion imaging, enable early detection of 
structural changes in axons and their myelin sheaths. Therefore, the axonal damage detected with 
diffusion MRI in the hippocampal, cerebellar, and pontine neurons of OSA patients, may occur 
before any reduction in grey matter detectable with VBM (39). Reduced concentrations of N-
acetylaspartate and choline in prefrontal white matter of OSA patients, compared to controls, 
measured using magnetic resonance spectroscopy (MRS) would also support this idea of early 
structural (white matter) changes in OSA patients (40). MRS changes have been found in the left 
hippocampus in a small number of OSA patients compared to controls. Here the reduced creatine-
containing compounds were correlated with OSA severity and cognitive impairment (41). These 





A potential criticism of our study is that the acquisition of MR images on two different 
scanners introduces a source of variance that may interfere with our ability to detect OSA-specific 
grey matter changes. Previous studies from our group (42, 43) have shown that differences 
between scanners can be adequately controlled by incorporating site as a covariate in the 
statistical model. Our study is also well balanced across sites, so the results from one site are 
unlikely to dominate our SPM findings. However, to investigate this issue further we generated low 
threshold maps (p<0.001), for both whole brain and cerebellum, for each centre independently 
using SPM8 and a smoothing kernel of 12 mm. This analysis showed that all changes were evident 
to some degree at low thresholds (p<0.001 uncorrected) in both sets of data independently. The 
cerebellar changes were evident in both whole brain and dedicated cerebellum (at lenient 
thresholds) analysis. 
It should be noted that the OSA patients were heavier than the healthy controls and it is 
possible that neck fat may have degraded the MR scans at the level of the cerebellum. Studies in 
which the OSA patients and controls are matched for BMI and neck size could test this issue, since 
the interrelationship between BMI and AHI makes it difficult to tease apart any effects statistically. 
 
Conclusions 
We found a reduction in grey matter volume in the right middle temporal gyrus and the left 
cerebellum, in a large sample of OSA patients, compared to non-apnoeic healthy controls. These 
neural deficits could lead to impaired motor processing, divided attention tasks and working 
memory. We speculate that such deficits could, when linked with excessive daytime sleepiness, 
negatively affect everyday tasks such as driving. 
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Table 1: Subject Characteristics 
 OSA Patients 
Mean (95% CI) 
Healthy Controls 













Age (years)  49.3 (44.9 - 53.7) 44.6 (40.7 – 48.5) 47.3 (44.2 – 50.3) 48.9 (45.0 – 52.9) 42.0 (38.4 – 45.7) 46.1 (43.2 – 49.0) 
BMI (Kg/m2) ‡ 31.4 (29.9 – 32.9) 32.6 (31.0 - 34.3) 32.0 (30.9 – 33.1) 24.7 (23.4 – 26.0) 25.3 (24.1 – 26.5) 25.0 (24.1 – 25.9) 
AHI (events/hour) ‡ 41.6 (33.2 - 49.9) 71.5 (65.0 – 77.9) 55.0 (48.3 – 61.6) 2.1 (1.3 – 2.9) 5.3 (3.8 – 6.9) 4.1 (3.0 – 5.1) 
ODI (events/hour) ‡ 33.0 (24.4 – 41.5 - 33.0 (24.4 – 41.5) 1.1 (0.5 – 1.7) - 1.1 (0.5 – 1.7) 
ESS‡ 13.0 (11.2 - 14.7) 13.5 (11.9 – 15.2) 13.2 (12.1 – 14.4) 4.8 (3.1 – 6.4) 5.0 (3.7 – 6.3) 4.9 (3.9 – 5.9) 
95% CI = 95% confidence interval; BMI = Body Mass Index; AHI = Apnoea/Hypopnoea Index; ODI = Oxygen Desaturation Index; ESS = 
Epworth Sleepiness Scale.  ‡ = significant difference between OSA patients and healthy controls, P<0.001 Normality was check using SPSS 
“normality plots.spv”. The plots appeared approximately normally distributed so we used independent samples t-test statistics to compare 
patients and controls.  
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Figure  1A (top) and 1B (bottom) 
 
Figure 1: Images show reductions in grey matter in OSA patients compared with controls.  Left 
panel shows “Glass brain” view, and right panel shows grey matter loss superimposed upon an MR 
  
22 
template. Views, in neurological orientation (left is left), from top left clockwise are, sagittal, coronal 
and transverse. 
Fig 1A: shows reductions in grey matter in right middle temporal gyrus of OSA patients compared 
with controls.  The voxel of maximum significance is marked as arrow head in the left panel. On the 
right panel the cross hairs (t = 4.05 – indicated by coloured bar) are located on the right at x = 52, y 
= 4, z = -22 mm (Montreal Neurological Institute (MNI) coordinates relative to anterior 
commissure). The images are thresholded to include clusters that survived the topological false 
detection rate threshold of p < 0.05. 
Fig 1B: shows reductions in grey matter in left cerebellum lobe VIIIb, but close to IX of OSA 
patients compared with controls. On the right panel the voxel of maximum significance (t = 5.95) is 
located on the left at x = -12, y = -62, z = -56 mm (MNI). Note: the location of the cerebellum and 





 Fig 2:  Images show statistically significant reductions in cerebellar grey matter in a subset of OSA 
patients compared with controls using a spatially unbiased infra-tentorial template (SUIT) (a) glass 
brain view (b) superimposed upon SUIT template. The image is displayed with a threshold of p < 
0.001 uncorrected. The voxel of maximum significance survives correction at p < 0.05 FWE 
corrected (t = 4.62 – indicated by coloured bar) and is located on the left at x = -14, y = -51, z = -48 
mm (Montreal Neurological Institute coordinates relative to anterior commissure). Two further 
maxima were located on the inferior edge of the cerebellum (t = 4.18: MNI: −50, −58, −55; t = 3.99: 
MNI: −35, −53, −62).  Note: the location of the cerebellum and the associated grey matter 




Fig 3: Sensitivity map of orthogonal planes passing through the anterior commisure (MNI: 0, 0, 0) . 
The map indicates the minimum change in grey matter volume required for each voxel to reach 
significance at P<0.001 uncorrected (smaller is better). The mid-point of the colour scale (0.067) is 
two standard deviations above the mean sensitivity of the voxels which were found to exhibit a 
significant difference between the groups (as illustrated in Fig 1A &1B). Cool colours (green and 
blue) indicate brain regions in which we would expect to be able to detect changes of 
approximately a similar magnitude, whereas warm colours indicate regions of relatively lower 

























Fig 4. Size effect maps showing the magnitude of the grey matter differences between controls and 
OSA. (a) Whole brain analysis: changes from the base of the cerebellum (z = -60 mm) to a level 
immediately below the level of the anterior commisure (z = -4) (b) Cerebellum (SUIT) analysis. 
Each panel shows horizontal slices at 2 mm intervals. The colour scale indicates the size of the 
effects across the brain (hotter colours black to red to yellow to white indicate greater grey matter 
(fractional change in grey matter volume) in control vs OSA). These maps indicate larger changes 
in the right temporal cortex and in the left cerebellum – changes that are consistent with the 
patterns of statistical significance.  
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